drugset / Trial / NCT00561197
An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase 1/ 2, open-label, single-center study of preoperative chemoradiotherapy and AT-101 in patients with locally advanced esophageal or gastroesophageal junction cancer.
Timeline
- Start
- 2007-08
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AT-101 | Small molecule | 10 mg | — |
| Background | Docetaxel | Small molecule | 20 mg/m2 | Intravenous |
| Background | fluorouracil | Small molecule | 300 mg/m2 | — |